A 58-year-old man presents for a routine annual physical. During the exam, he mentions an intermittent sensation like a “rush of anxiety” that begins in the abdomen and chest and radiates to the head.

The incidence of pulmonary arterial hypertension (PAH) has increased worldwide over the past three decades, although death rates and disability-adjusted life year (DALY) rates related to the ...

known as Anomalous Left Anterior Descending Coronary Artery Arising from Pulmonary Artery (ALADAPA), was confirmed through a CT coronary angiogram. Only about 10 such cases have been documented ...

The Prognostic Value of Right Ventricular-Pulmonary Artery Coupling in Heart Valve Interventions: A Systematic Review and Meta-Analysis ...

Gradient Denervation Technologies is a Paris-based medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension.

A woman says her chiropractor tore an artery in her neck during a routine adjustment, causing her to be bedridden in “constant pain.” ...

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and ...

Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD) with a progressive pulmonary fibrosis phenotype ...

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and ...

Pulmonary artery denervation has become a promising therapeutic intervention in the management of pulmonary hypertension. While our findings suggest a substantial role for PADN in treatment ...